Real-world experience with ocrelizumab in primary Progressive multiple sclerosis: Insights from the MSOCR-P cohort, a MSBase Registry sub-study

Butzkueven H., Spelman T., Ozakbas S., Laureys G., Van Hijfte L., Alroughani R., ...More

38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Amsterdam, Netherlands, 26 - 28 October 2022, vol.28, pp.384-386

Publication Type: Conference Paper / Summary Text
Volume: 28
City: Amsterdam
Country: Netherlands
Page Numbers: pp.384-386
Dokuz Eylül University Affiliated: Yes